Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 24, 2024 02:00 ET
|
LIfT BioSciences
Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting London, 24 May 2024 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly...
BW ENERGY: FIRST QUARTER RESULTS 2024
May 24, 2024 01:30 ET
|
BW Energy Limited
BW ENERGY FIRST QUARTER RESULTS 2024 HIGHLIGHTS Q1 EBITDA of USD 109.7 million and net profit of USD 47.4 millionQ1 gross production of 3.1 million barrels with 2.5 million net to BW...
ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres
May 23, 2024 21:19 ET
|
ONWARD Medical NV
Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine veröffentlicht Einreichung des De-Novo-Antrags für das ARC-EX®-System bei der FDA Erfolgreiche Einwerbung von 20 Mio. EUR an Eigenkapital ...
ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
May 23, 2024 21:19 ET
|
ONWARD Medical NV
La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande...
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
May 23, 2024 01:30 ET
|
ONWARD Medical NV
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine
May 22, 2024 13:13 ET
|
ONWARD Medical NV
Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine veröffentlicht Besprechung der Ergebnisse der Zulassungsstudie in einem Webcast in dieser Woche mit Führungskräften des Unternehmens,...
ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
May 22, 2024 13:13 ET
|
ONWARD Medical NV
La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT ONWARD Medical présentera les résultats de cet essai pivot à l’occasion d’une téléconférence organisée cette semaine...
The Vita Coco Company to Participate in the William Blair Growth Stock Conference
May 22, 2024 08:00 ET
|
The Vita Coco Company
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today...
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024
May 22, 2024 07:00 ET
|
Atea Pharmaceuticals, Inc.
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A...
LIFT intersects 35 m at 1.32% Li2O at its Shorty pegmatite, Yellowknife Lithium Project, NWT
May 22, 2024 03:05 ET
|
Li-FT Power Ltd.
VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) -- Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to report assays from 12 drill holes...